ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 159

Power Doppler Continuous Quantitative Assessment Techniques Is Faster Than Semiquantitative Assesment in Identification of Therapeutic Response

Florian Berghea1, Violeta Vlad2, Mihai Bojinca3, Luminita Enache4 and Ruxandra Ionescu5, 1Department of Internal Medicine and Rheumatology “Sf. Maria” Hospital, Bucharest, Romania, 2RCRD Research Center, Bucharest, Romania, 3Carol Davila University of Medicine and Pharmacy, Internal Medicine and Rheumatology, Cantacuzino Hospital, Bucharest, Romania, 4Rheumatology, 'Dr. Ion Stoia' Clinical Center of Rheumatic Diseases, Bucharest, Romania, 5University of Medicine and Pharmacy “Carol Davila”, Department of Internal Medicine and Rheumatology “Sf. Maria” Hospital, Bucharest, Romania

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Doppler ultrasound, rheumatoid arthritis (RA) and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Imaging of Rheumatic Diseases Poster I: Ultrasound, Optical Imaging and Capillaroscopy

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Power Doppler Ultrasound (PD) is widely used to assess the activity of rheumatic diseases (especially in Rheumatoid Arthritis).  Up to now a series of qualitative / semiquantitative scales have been proposed in order to facilitate a reliable evaluation of a PD image most of them in two to four steps. A true quantitative assessment of PD image is rarely done; in most of the cases it is performed by manual selection of the worst case scenario frame (i.e. the frame with the highest amount of Doppler signal) from a recorded cine-loop. The feasibility of this technique is questionable: in a previous work we demonstrated the inferiority of manual vs. computerized selection both in terms of quality of the process and the time spent. However the independent software solutions for quantitative analysis of Doppler image (i.e. the analysis of the total number of colorized pixels from a region of interest) are now available; we are able to measure in a timely manner not just the ratio between the colorized and grey pixels (CTR) from a certain region in a single frame but all CTRs of all frames captured in a cine-loop (Continuous Quantitative Assessment – CQA). The objective of our study was to assess the ability of CQA technique to identify changes of PD signal earlier than the classical semiquantitative assessment.  

Methods:

24 cases of active RA have been examined according to AIUM guidelines for dorsal aspect of radiocarpal and midcarpal joints. A cine-loop of 4 seconds has been recorded for each case before the administration of an i.v. dose of dexamethasone and after 0.5, 1, 2, 6 and 24 hours. All the recordings have been evaluated independently both in semiquantitative (SQ) and in CQA technique (by using a registred software (RETINA®). For CQA we computed mean and peak CTRs. C-reactive protein was measured before and after 24 hour of therapeutical intervention: a 20% decrease defined the reponders. A one-way repeated measures ANOVA was conducted to determine whether there were statistically significant differences between SQ and CQA scores. Responsiveness of SQ and CQA scores was calculated using Relative Reduction (RR) over time.

Results: 23 cases presented a 20% decrease of CRP level and have been included in the analysis. The therapeutic intervention elicited statistically significant changes in SQ and CQA scores for synovitis (tenosynovitis was not included in this study) as described in the table. 

Timepoint

No of responders identified by SQ

No of responders identified by Mean CQA

No of responders identified by Peak CQA

P (SQ vs Mean CQA)

0

NA

NA

NA

NA

0.5

0

2

2

<0.05

1

1

4

5

<0.05

2

1

7

8

<0.05

6

2

9

9

<0.05

24

4

12

15

<0.05

The responsiveness of SQ was inferior to any CQA score (p<0.05). However the mean and peak CQA scores correlated well (0.78 for p<0.001) – no separate scores seems to be needed. 

Conclusion:

To the best of our knowledge, this is the first study to document the difference between semiquantitative and continuous quantitative PD assessment techniques. The CQA seems to offer the opportunity to identify the therapeutic response earlier than the current approach. The method should be tested in different therapeutic scenarios and in larger groups, too.  


Disclosure: F. Berghea, None; V. Vlad, None; M. Bojinca, None; L. Enache, None; R. Ionescu, None.

To cite this abstract in AMA style:

Berghea F, Vlad V, Bojinca M, Enache L, Ionescu R. Power Doppler Continuous Quantitative Assessment Techniques Is Faster Than Semiquantitative Assesment in Identification of Therapeutic Response [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/power-doppler-continuous-quantitative-assessment-techniques-is-faster-than-semiquantitative-assesment-in-identification-of-therapeutic-response/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/power-doppler-continuous-quantitative-assessment-techniques-is-faster-than-semiquantitative-assesment-in-identification-of-therapeutic-response/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology